Psychiatry & Neurology Doctors in Hanover, NH Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Ralph S Albertini, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 6 E South St, Hanover, NH 03755 Phone: 603-643-6765

Dr. Regan Ruth Stanger, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 23 S Main St, Suite 2b, Hanover, NH 03755 Phone: 603-277-9110

Benita J Walton, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 45 Lyme Rd Ste 204a, Hanover, NH 03755 Phone: 603-277-9894    Fax: 603-277-9896

Carolyn Solzhenitsyn, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 23 S Main St, Suite 2b Hanover Psychiatry, Hanover, NH 03755 Phone: 603-277-9110    Fax: 603-277-9154

News Archive

ACT's hESC line MA135 approved for federal funding

Advanced Cell Technology, Inc. announced today that human embryonic stem cell line MA135 was unanimously approved for federal funding at the 100th Meeting of the Advisory Committee to the Director National Institutes of Health. In addition to MA135, seven additional stem cell lines derived at ACT are currently under review by the NIH.

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Although most commonly associated with military combat, post-traumatic stress disorder (PTSD) can occur in civilians, too - and with consequences that are just as serious, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). PTSD is a type of anxiety disorder that occurs after a person experiences a traumatic event involving physical injury, and occurs in 20 to 51 percent of patients with an orthopaedic injury.

Allergan acquires Serica Technologies

Morningside Technology Ventures, Prism VentureWorks, and Ivy Capital Partners are pleased to announce the acquisition of their portfolio company, Serica Technologies, Inc. by Allergan, Inc. Serica is a growth-stage medical device company focused on the development of biodegradable silk-based scaffolds for use in tissue regeneration in numerous therapeutic areas. Following the acquisition, Serica became a wholly owned subsidiary of Allergan.

Phase 1B/2 clinical study to evaluate efficacy of PMX-60056 in reversing heparin levels initiated

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B/2 dose-ranging clinical study with its anticoagulant reversing agent, PMX-60056. The study is intended to demonstrate the safety and efficacy of PMX-60056 in reversing varying heparin levels, including the highest levels commonly used in surgical settings.

Read more Medical News

› Verified 4 days ago